Found 34 results
Author [ Title(Desc)] Type Year
Filters: Author is Fast, P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., and Tartaglia, J., A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers, J Infec Dis, vol. 180, no. 2, pp. 290-298, 1999.
S. Vasan, Schlesinger, S. J., Chen, Z., Hurley, A., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Gardiner, D. F., Zaharatos, G. J., Caskey, M., Q, F., Schmidt, C., Huang, Y., Seamons, L., Ho, M., Lombardo, A., Gilmour, J., Keefer, M. C., Fast, P., and Ho, D. D., Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
O. G Manyonyi, Jaoko, W., Wakasiaka, S., Bwayo, J., Achola, N. J., Schmidt, C., Bhatt, K., Ogutu, H., K’owino, D., Dally, L., Malogo, R., and Fast, P., Challenges Experienced By the Clinical Team During The Conduct of HIV Vaccine Clinical Trials in Kenya, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
H. Ogutu, Wakasiaka, S., Malogo, R., Ndambuki, R., Nyange, J., Omosa, G., Anzala, O., Bwayo, J., Fast, P., Schmidt, C., Verlinde, C., Smith, C., Ndinya-Achola, J., and Jaoko, W., Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
E. Karita, Anzala, O., Gazzard, B., Bergin, P., Nyombayire, J., Omosa, G., ,, Dally, L., Barin, B., Inoue, M., Hara, H., Hironaka, T., Shu, T., Hasegawa, M., Matano, T., Sayeed, E., Parks, C., Ackland, J., Fast, P., Gilmour, J., Cox, J., Lombardo, A., and Laufer, D., Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers, in HIVR4P (HIV Research for Prevention), Cape Town, South Africa, 2014.
E. Karita, Ketter, N., Price, M., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., Jaoko, W., Mutua, G., Ruzagira, E., Mulenga, J., Sanders, E., Mwangome, M., Allen, S., Bwanika, A., Bahemuka, U., Awuondo, K., Omosa, G., Farah, B., Amornkul, P., Birungi, J., Yates, S., Stoll-Johnson, L., Gilmour, J., Stevens, G., Shutes, E., Manigart, O., Hughes, P., Dally, L., Scott, J., Stevens, W., Fast, P., and Kamali, S., CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa, PLoS ONE, vol. 4, no. 2, p. e4401, 2009.
P
V. D. Ramanathan, Kumar, M., Jayashri, M., Sathyamoorthy, P., Narayanan, P. R., Solomon, S., Cox, J., Sayeed, E., Ackland, J., Verlinde, C., Vooijs, D., Loughran, K., Barin, B., Lombardo, A., Gilmour, J., Stevens, G., Kochhar, S., Excler, J., and Fast, P., A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara (rMVA) Virus Preventive Multigenic HIV Subtype C Vaccine (TBC-M4) in Indian Volunteers, in Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms, Bangkok, Thailand, 2008.
E. Vardas, Kaleebu, P., Bekker, L., Hoosen, A., Chomba, E., Johnson, P., Anklesaria, P., Birungi, J., Barin, B., Boaz, M., Cox, J., Lehrman, J., Stevens, G., Gilmour, J., Tarragona, T., Hayes, P., Lowenben, S., Kizito, E., Fast, P., Heald, A., and Schmidt, C., A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus, AIDS Res Hum Retroviruses, vol. 26, pp. 933-942, 2010.
E. Vardas, Kaleebu, P., Bekker, L., Hoosen, A., Chomba, E., Johnson, P., Heald, A., Anklesaria, P., Dally, L., Boaz, M., Fast, P., and Schmidt, C., A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
B. Peters, Jaoko, W., Anzala, O., Judges, L., G Manyonyi, O., Sharp, A., Gray, K., Fast, P., Schmidt, C., Gilmour, J., Smith, C., Dally, L., Loughran, K., Farah, B., Tarragona, T., Hayes, P., McMichael, A., Hanke, T., and Bwayo, J., Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate, in AIDS Vaccine 2005 International Conference, Montreal, Quebec, Canada, 2005.
M. Keefer, Gilmour, J., Hayes, P., Gill, D., Kopycinski, J., Cheeseman, H., Cashin-Cox, M., Naarding, M., Clark, L., Fernandez, N., Bunce, C., Hay, C., Welsh, S., ,, Loughran, K., Barin, B., Cormier, E., Cox, J. H., Fast, P., and Excler, J., A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults, PLoS One, vol. 7, p. e41936, 2012.
G. Omosa-Manyonyi, Mpendo, J., Ruzagira, E., Kilembe, W., Chomba, E., Roman, F., Bourguignon, P., Koutsoukos, M., Collard, A., Voss, G., Laufer, D., Stevens, G., Hayes, P., Clark, L., Cormier, E., Dally, L., Barin, B., ,, Gilmour, J., Cox, J., Fast, P., and Priddy, F., A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults, PLoS One, vol. 10, p. e0125954, 2015.
V. Ramanathan, Kumar, M., Mahalingam, J., Narayanan, P., Solomon, S., Boaz, M., Sayeed, E., Scharton-Kersten, T., Seth-Smith, M., Verlinde, C., Vooijs, D., Barin, B., Lombardo, A., Kochhar, S., Excler, J., and Fast, P., A Phase I Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara Virus (TBC-M4) Multigenic HIV Subtype C Vaccine, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
M. J. McElrath, Corey, L., Montefiori, D., Wolff, M., Schwartz, D., Keefer, M., Belshe, R., Graham, B. S., Matthews, T., Wright, P., Gorse, G., Dolin, R., Berman, P., Francis, D., Duliege, A. M., Bolognesi, D., Stablein, D., Ketter, N., and Fast, P., A Phase II Study of Two HIV-1 Envelope Vaccines Comparing their Immunogenicity in Populations at Risk for Acquiring HIV-1 Infection, AIDS Res HumRetroviruses, vol. 16, pp. 907-19, 2000.
A. Guimarães-Walker, Mackie, N., McMichael, A., Weber, J., McCormack, S., Cebere, I., Kay, R., Hanke, T., Dally, L., Gibiansky, L., Legg, K., DeSouza, C., Hayes, P., Gilmour, J., and Fast, P., Priming with a Candidate HIV-1 Clade A DNA Vaccine Followed by Boosting with an HIV-1 Clade A MVA Vaccine in Volunteers at Low risk of HIV Infection, in AIDS Vaccine 2004 International Conference, Lausanne, Switzerland, 2004.
R. Belshe, Bolognesi, D., Clements, M., Corey, L., Fast, P., Graham, B., Keefer, M., Mestecky, J., Mulligan, M., and Stablein, D., Progress in HIV-1 Vaccine Development, in 2nd National Conference on Human Retroviruses and Related Infections, Washington DC, 1995.